Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1104 | 1105 | (Page 1106) | 1107 | 1108 | .... | 1118 | newer

    0 0

     



    (EMAILWIRE.COM, December 01, 2018 ) The Healthcare Robotics Market report from database of Qurate provides detailed description of current scenario as well as future outlook of global market. This study entails significant information and data in relation with noteworthy market components such as market segmentation, competitive insights, regional analysis, key companies, market share and forecast.

    Industry Outlook
    Healthcare Robotics is a field that deals with combined medical & technological fields. Robots in healthcare are helping the medical personals for performing tasks that take lot of time & also making the medical process safer & more cost-effective. Healthcare Robotics is helpful for performing surgeries at small places & to handle risky substances. Healthcare Robotics finds a wide application is medical procedures, while some more technologies are under research. Use of robotics in Healthcare is increasing due to factors like; rise in number of elderly population, increase in number of minimally invasive surgical (MIS), rise in number of systems providing high resolution imaging, fine control & haptic feedback, reduction in treatment cost with increased quality, increase in technical advancement, severe shortage of medical personals, etc. Therefore, the Healthcare Robotics Market is anticipated to expand and has tremendous scope during the forecast period. The global Healthcare Robotics Market is anticipated to flourish in the future by growing at a significantly higher CAGR.

    Get Free Sample Report@ www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-57999

    Competitive Analysis
    The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

    The leading players in the Healthcare Robotics market are
    Biotek Instruments Inc.
    Roche Holding AG
    Hocoma
    Aurora Biomed Inc.
    Irobot Corporation
    Mazor Robotics Ltd.
    Hansen Medical Inc.
    Ekso Bionics Holdings Inc.
    Kirby Lester LLC
    ZOLL Medical Corp.
    Titan Medical Inc.
    Accuray Inc.
    Intuitive Surgical Inc.
    Varian Medical Systems
    MAKO Surgical Corp.

    Enquiry about Report@ www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-57999

    Market Segmentation
    The global Healthcare Robotics Market is based on segment, by Product, By Components and By Application.
    Healthcare Robotics Market, By Product
    Robotic Catheters
    Pharmacy & Hospital Automation Robots
    Surgical Robots
    Non-Invasive Radiosurgery Robots
    Rehabilitation Robots
    Telemedicine Robots

    Healthcare Robotics Market, By Components
    Visualization Systems
    Safety Systems
    Power Resources
    Software Platforms
    Locomotion Systems
    User Interface

    Healthcare Robotics Market, By Application
    Laparoscopic
    Orthopedic
    Neurology
    Cardiology
    Others

    Buy This Report@ www.qurateresearch.com/report/buy/HnM/QBI-CMR-HnM-57999/ (Priced at USD 3800)

    Regional Insights
    On a global front, the Healthcare Robotics Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Healthcare Robotics Market due to increasing knowledge amongst the people about the latest and improved technologies.

    Some of the key questions answered by the report are:
    What was the market size in 2014 and forecast from 2015 to 2025?
    What will be the industry market growth from 2015 to 2025?
    What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
    What are the major segments leading the market growth and why?
    Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

    Get Discount on this Report@ www.qurateresearch.com/report/discount/HnM/QBI-CMR-HnM-57999


    Nehal Chinoy
    +919881074592
    nehal@qurateresearch.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 02, 2018 ) According to the new market research report “Endodontics Market by Instruments (Scalers, Apex Locator, Motors, Handpiece, Laser), Consumables (Access Cavity Preparation, Endodontic Files, Burs, Drill, Lubricant, Obturation), End User (Clinic, Hospital) - Global Forecast to 2022", published by MarketsandMarkets™, The global endodontics market is projected to reach USD 1.61 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 5.1% during the forecast period. Growth in this market is attributed to the rapid growth in the geriatric population, increasing number of dentists and dental practices, rising dental tourism, increasing dental expenditure, and an increase in disposable incomes.

    Don’t miss out on business opportunities in “Endodontics Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2D2Wv74
    The consumables segment to dominate the endodontics market during the forecast period

    Based on product, the endodontics market is segmented into consumables and instruments. The consumables segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the growing number of root canal procedures globally.

    Dental clinics to witness the highest growth rate during the forecast period

    On the basis of end users, the endodontics market is segmented into dental clinics, dental hospitals, and dental academic & research institutes. The dental clinics segment accounted for the major share of the global endodontics market and is also expected to register the highest CAGR during the forecast period. The large share of this end-user segment is attributed to the increasing number of dental clinics especially in emerging markets, rapid adoption of advanced technologies in these settings, and growth in the target patient population.

    Browse and in-depth TOC on “Endodontics Market”
    102 - Tables

    38 - Figures

    166 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/endodontics-market-222473576.html

    Europe dominated the market in 2016

    Europe accounted for the largest share of the endodontics market in 2016, followed by North America. The large share of this region is attributed to the increasing prevalence of dental diseases, growth in the aging population, increasing demand for advanced dental procedures, growing dental tourism in some European countries, increasing number of dental clinics and hospitals, and increasing dental care expenditure in countries such as Germany and the UK.

    The prominent players in the endodontics market are DENTSPLY SIRONA (US), Danaher Corporation (US), Ivoclar Vivadent (Liechtenstein), Ultradent Products (US), Septodont Holding (France), FKG Dentaire (Switzerland), Brasseler USA (US), MICRO-MEGA (France), DiaDent Group International (Canada), MANI (Japan), COLTENE Holding (Switzerland), and VOCO (Germany).

    Request for Free Sample Report @ http://bit.ly/2qs90S2
    Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting
    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh

    MarketsandMarkets™ INC.
    630 Dundee Road

    Suite 430

    Northbrook, IL 60062

    USA: 1-888-600-6441

    Email: sales@marketsandmarkets.com

    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 02, 2018 ) According to the new market research report “Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023", published by MarketsandMarkets™, The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

    Don’t miss out on business opportunities in “Bioinformatics Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2DzRN1R
    Early buyers will receive 10% customization on reports.

    Based on product and service, the bioinformatics platforms segment is projected to grow at the highest CAGR in the market during the forecast period

    On the basis of product & service, the market is broadly segmented into knowledge management tools, bioinformatics platforms, and services. The bioinformatics platform segment is projected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the increasing usage of different bioinformatics platforms in various genomic and proteomics applications. Additionally, there is an increase in the use of bioinformatics platforms in drug discovery and development, which also contributes to the growth of the market.

    Based on applications, the genomics segment is estimated to account for the largest share of the market in 2018

    On the basis of applications, the global bioinformatics market is divided into genomics, chemoinformatics and drug design, proteomics, transcriptomics, and metabolomics. In 2018, the genomics segment is expected to account for the largest share of the bioinformatics market. The rising application of genomics in personalized and preventive medicine is positively affecting market growth.

    Based on sector, the medical biotechnology segment is estimated to account for the largest share of the market in 2018

    On the basis of sector, the global bioinformatics market is divided into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, and forensic biotechnology. The medical biotechnology is again subdivided into drug discovery & development, clinical diagnostics & precision medicine, reproductive health. In 2018, the medical biotechnology segment is estimated to account for the largest share of the bioinformatics market. The rising adoption of bioinformatics tools in pharmaceutical and clinical applications is driving market growth.

    Browse and in-depth TOC on “Bioinformatics Market”
    189 - Tables

    27 - Figures

    195 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

    North America is expected to dominate the market in 2018

    Among the four geographic regions, North America is expected to account for the largest share of the bioinformatics market in 2018, followed by Europe, APAC, and the RoW. The large share of North America is attributed to the steady funding from the government and private sector for life sciences research and bioinformatics.

    Market Players

    The bioinformatics market is highly competitive due to the presence of a large number of players. Few of the major companies in bioinformatics market are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US), and DNASTAR (US).

    Request for Free Sample Report @ http://bit.ly/2FlF2JR

    Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting
    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatics-market.asp
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 04, 2018 ) The pediatric orthopedic implants market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pediatric orthopedic implants market based on type, application, and end user. It also provides market size and forecast till 2025 for overall pediatric orthopedic implants market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

    An exclusive Pediatric Orthopedic Implants Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Pediatric Orthopedic Implants Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Pediatric Orthopedic Implants Market. Additionally, the report also highlights market entry strategies for various companies across the globe.



    Get sample PDF copy of Research@ https://www.theinsightpartners.com/sample/TIPMD00002021?nb



    Worldwide Pediatric Orthopedic Implants Market Analysis to 2025 is a specialized and in-depth study of the Pediatric Orthopedic Implants industry with a focus on the global market trend. The report aims to provide an overview of global Pediatric Orthopedic Implants Market with detailed market segmentation by product/application and geography. The global Pediatric Orthopedic Implants Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Air Cargo players and offers key trends and opportunities in the market.

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Pediatric Orthopedic Implants Market based on product and application. It also provides market size and forecast till 2025 for overall Pediatric Orthopedic Implants Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

    Also, key Pediatric Orthopedic Implants Market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPMD00002021?nb

    Reason to Buy

    - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pediatric Orthopedic Implants Market
    - Highlights key business priorities in order to assist companies to realign their business strategies.
    - The key findings and recommendations highlight crucial progressive industry trends in the Pediatric Orthopedic Implants Market, thereby allowing players to develop effective long term strategies.
    - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
    About Us

    The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

    We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.



    The Insight partners,

    Phone: +1-646-491-9876
    Email: sales@theinsightpartners.com

    Website: http://www.theinsightpartners.com/


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 04, 2018 ) Procedure tray provides the benefit of less waste generation, which is expected to be a major driving factor for the market growth in the coming years. government regulations encouraging the use of single use sterile instruments for surgical procedures is anticipated to provide growth opportunities for the players operating in the market during the forecast period.

    An exclusive Procedure Trays Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Procedure Trays Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Procedure Trays Market. Additionally, the report also highlights market entry strategies for various companies across the globe.


    Get sample PDF copy of Research@ https://www.theinsightpartners.com/sample/TIPHE100001227/?nb


    Worldwide Procedure Trays Market Analysis to 2025 is a specialized and in-depth study of the Procedure Trays industry with a focus on the global market trend. The report aims to provide an overview of global Procedure Trays Market with detailed market segmentation by product/application and geography. The global Procedure Trays Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Air Cargo players and offers key trends and opportunities in the market.

    Procedure Trays Market

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Procedure Trays Market based on product and application. It also provides market size and forecast till 2025 for overall Procedure Trays Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

    Also, key Procedure Trays Market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001227/?nb

    Reason to Buy

    - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Procedure Trays Market
    - Highlights key business priorities in order to assist companies to realign their business strategies.
    - The key findings and recommendations highlight crucial progressive industry trends in the Procedure Trays Market, thereby allowing players to develop effective long term strategies.
    - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
    About Us

    The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

    We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.



    The Insight partners,

    Phone: +1-646-491-9876
    Email: sales@theinsightpartners.com

    Website: http://www.theinsightpartners.com/


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 04, 2018 ) Surgical Instrument Tracking Systems Market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

    Healthcare resource management has gained importance with increasing concerns on safety and security of medical devices and instruments. Surgical instrument tracking devices keep the track of surgical instruments and provide comprehensive reporting to the healthcare provider. These devices offer various advantages such as efficient workflow management, proper resources utilization and reduce cost. Therefore, majority of hospitals and surgical centers incorporate such systems for improving productivity and accountability of the organization.

    An exclusive Surgical Instrument Tracking Systems Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Surgical Instrument Tracking Systems Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Surgical Instrument Tracking Systems Market. Additionally, the report also highlights market entry strategies for various companies across the globe.



    Get sample PDF copy of Research@ https://www.theinsightpartners.com/sample/TIPHE100001271?nb



    Worldwide Surgical Instrument Tracking Systems Market Analysis to 2025 is a specialized and in-depth study of the Surgical Instrument Tracking Systems industry with a focus on the global market trend. The report aims to provide an overview of global Surgical Instrument Tracking Systems Market with detailed market segmentation by product/application and geography. The global Surgical Instrument Tracking Systems Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Air Cargo players and offers key trends and opportunities in the market.

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Surgical Instrument Tracking Systems Market based on product and application. It also provides market size and forecast till 2025 for overall Surgical Instrument Tracking Systems Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.




    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001271?nb

    Reason to Buy

    - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Surgical Instrument Tracking Systems Market
    - Highlights key business priorities in order to assist companies to realign their business strategies.
    - The key findings and recommendations highlight crucial progressive industry trends in the Surgical Instrument Tracking Systems Market, thereby allowing players to develop effective long term strategies.
    - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
    About Us

    The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

    We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.



    The Insight partners,

    Phone: +1-646-491-9876
    Email: sales@theinsightpartners.com

    Website: http://www.theinsightpartners.com/


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 04, 2018 ) Vital signs monitoring devices mainly track vital parameters of the body such as body temperature, pulse rate, respiratory rate, and blood pressure. These devices determine the changes in these parameters helping the healthcare provider to decide the line of treatment in case of an emergency. These devices continuously monitor patients in critical care units of hospitals and surgical centers. Vital sign monitoring is also important in pediatric care in case of premature birth of the child and other health issues.

    An exclusive Vital Signs Monitoring Devices Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Vital Signs Monitoring Devices Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Vital Signs Monitoring Devices Market. Additionally, the report also highlights market entry strategies for various companies across the globe.



    Get sample PDF copy of Research@ https://www.theinsightpartners.com/sample/TIPHE100001258?nb



    Worldwide Vital Signs Monitoring Devices Market Analysis to 2025 is a specialized and in-depth study of the Vital Signs Monitoring Devices industry with a focus on the global market trend. The report aims to provide an overview of global Vital Signs Monitoring Devices Market with detailed market segmentation by product/application and geography. The global Vital Signs Monitoring Devices Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the Air Cargo players and offers key trends and opportunities in the market.

    The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Vital Signs Monitoring Devices Market based on product and application. It also provides market size and forecast till 2025 for overall Vital Signs Monitoring Devices Market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

    Also, key Vital Signs Monitoring Devices Market players influencing the market are profiled in the study along with their SWOT analysis and market strategies. The report also focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001258?nb

    Reason to Buy

    - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Vital Signs Monitoring Devices Market
    - Highlights key business priorities in order to assist companies to realign their business strategies.
    - The key findings and recommendations highlight crucial progressive industry trends in the Vital Signs Monitoring Devices Market, thereby allowing players to develop effective long term strategies.
    - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
    About Us

    The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

    We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.



    The Insight partners,

    Phone: +1-646-491-9876
    Email: sales@theinsightpartners.com

    Website: http://www.theinsightpartners.com/


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 04, 2018 ) X-Ray Photoelectron Spectroscopy is also known as Electron Spectroscopy for Chemical Analysis (ESCA), it is most extensively used for surface analysis to measure element composition and provides valuable quantitative and chemical state information of the material under examination. 3-D distribution information can be obtained by scanning the micro focused x-ray beam across the sample surface.

    The x-ray photoelectron spectroscopy market is expected to grow significantly due to the factors such as rise in the demand of x-ray photoelectron spectroscopy for the drug development processes. The technological advancement has helped to develop the technology such as hard x-ray photoelectron spectroscopy that, has enabled to drive the market growth. The support from the FDA is also widening the way for various opportunities for the players to enter into the market in coming future.



    Get sample PDF copy of Research@ https://www.theinsightpartners.com/sample/TIPHE100001237?nb



    The List of Companies

    1. Thermo Fisher Scientific Inc.
    2. Tecotec Group
    3. Kratos Analytical Ltd.
    4. EAG Inc.
    5. Intertek Group plc
    6. Scienta Scientific AB
    7. JEOL Ltd.
    8. ULVAC-PHI, INCORPORATED.
    9. Enviro Analytical Instruments GmbH
    10. Yokogawa Electric Corporation

    The “Global X-Ray Photoelectron Spectroscopy Market Analysis to 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global x-ray photoelectron spectroscopy market with detailed market segmentation by type, application and geography. The global x-ray photoelectron spectroscopy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.

    The segmentation of the x-ray photoelectron spectroscopy market is segmented on the basis of type and application. The type segment is segmented into contamination detection, density estimation and element detection, and others. On the basis of application the market is segmented as healthcare, aerospace, automotive and others.

    The report provides a detailed overview of the industry and forecast of the global x-ray photoelectron spectroscopy market based on type and application. It also provides market size and forecast till 2025 for overall x-ray photoelectron spectroscopy market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.



    Inquiry for Discount: https://www.theinsightpartners.com/discount/TIPHE100001237?nb



    North America region is expected hold the largest market followed by the Europe for x-ray photoelectron spectroscopy due to the factors such as rising supports from the regulatory bodies that motivates to manufacture more devices with the technological advancements. Asia Pacific region is expected to be the fastest growing market for x-ray photoelectron market as the constant developments are being done on the healthcare industry and also the infrastructure policies are also helping the players to enter into the market in this region. Therefore, owing to these factors the market for x-ray photoelectron spectroscopy is expected to grow significantly in coming future.

    The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America.

    About Us
    The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
    We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.

    Contact us:
    The Insight Partners,
    533, 5th Floor,
    Amanora Chambers, East Block, Amanora Township,
    Kharadi Road, Hadapsar, Pune-411028
    Call: +1-646-491-9876
    Email: sales@theinsightpartners.com


    Sameer Joshi
    +1-646-491-9876
    sam@theinsightpartners.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 20+ products along with 20+ companies involved.

    Get a Sample Report: https://www.reportsweb.com/inquiry&RW00012283175/sample

    Top Key Players: -
    Zydus Cadila
    Tiziana Life Sciences
    Pharmakea Therapeutics
    Novartis
    NGM Biopharmaceuticals
    Kowa Pharmaceutical
    Gilead Sciences
    GenKyoTex
    Genfit
    Fast Forward Pharmaceuticals
    Enanta Pharmaceuticals
    Eisai
    CymaBay Therapeutics
    Arena Pharmaceuticals
    Virobay

    Products covered by Phase
    -Phase II and Phase I
    -Pre-clinical
    -Inactive (Dormant and Discontinued)

    Overview of pipeline development activities for Primary Biliary Cirrhosis
    Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

    Therapeutic segmentation of products for Primary Biliary Cirrhosis
    The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283175/discount

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    -Provides an overview of therapeutic pipeline activity for Primary Biliary Cirrhosis across the complete product development cycle including all clinical and non-clinical stages
    -It comprises of detailed profiles of Primary Biliary Cirrhosis therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
    -Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    -Coverage of dormant and discontinued pipeline projects across Primary Biliary Cirrhosis

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283175/buying

    Reasons to Buy
    -Establish a comprehensive understanding of the current pipeline scenario across Primary Biliary Cirrhosis to formulate effective R&D strategies
    -Assess challenges and opportunities that influence Primary Biliary Cirrhosis R&D
    -Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    -Identify the relationship between the products and use it for target finding, drug repurposing, and precision medicine
    -Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Primary Biliary Cirrhosis to enhance and expand business potential and scope
    -Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 150+ products along with 120+ companies involved.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW00012283176/sample

    Top Key Players: -
    Aciont
    Acucela
    Adalta
    Adverum Biotechnologies
    Aerie Pharmaceuticals
    Aeris
    Alcon Research
    Alimera sciences
    Alkeus Pharmaceuticals
    Allegro Opthalmics
    Allergan
    Altacor
    Amarantus
    Apellis Pharmaceuticals
    Apexigen
    Applied Genetic Technologies Corporation (AGTC)
    Ascendis Pharma

    Products covered by Phase
    -Phase III, Phase II and Phase I
    -Pre-clinical and Discovery
    -Inactive (Dormant and Discontinued)

    Overview of pipeline development activities for Retinal Degeneration
    Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

    Therapeutic segmentation of products for Retinal Degeneration
    The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283176/discount

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    -Provides an overview of therapeutic pipeline activity for Retinal Degeneration across the complete product development cycle including all clinical and non-clinical stages
    -It comprises of detailed profiles of Retinal Degeneration therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
    -Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    -Coverage of dormant and discontinued pipeline projects across Retinal Degeneration

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283176/buying

    Reasons to Buy
    -Establish a comprehensive understanding of the current pipeline scenario across Retinal Degeneration to formulate effective R&D strategies
    -Assess challenges and opportunities that influence Retinal Degeneration R&D
    -Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    -Identify the relationship between the products and use it for target finding, drug repurposing, and precision medicine
    -Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Retinal Degeneration to enhance and expand business potential and scope
    -Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs
    of the report
    -Provides an overview of therapeutic pipeline activity for Retinal Degeneration across the complete product development cycle including all clinical and non-clinical stages
    -It comprises of detailed profiles of Retinal Degeneration therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
    -Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    -Coverage of dormant and discontinued pipeline projects across Retinal Degeneration


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 55+ products along with 50+ companies involved.

    Get a Sample Report: https://www.reportsweb.com/inquiry&RW00012283177/sample

    Top Key Players: -
    Acceleron
    Actelion
    Addex Therapeutics
    Advinus Therapeutics
    AesRx
    Angiocrine Bioscience
    ArQule
    Astellas
    AstraZeneca
    Bioverativ
    Bluebird Bio
    Bristol-Myers Squibb
    Centocor
    Complexa

    Products covered by Phase
    -Phase III, Phase II, Phase I and IND
    -Pre-clinical and Discovery
    -Unknown Stage
    -Inactive (Dormant and Discontinued)

    Overview of pipeline development activities for Sickle Cell Disease
    Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

    Therapeutic segmentation of products for Sickle Cell Disease
    The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283177/discount

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    -Provides an overview of therapeutic pipeline activity for Sickle Cell Disease across the complete product development cycle including all clinical and non-clinical stages
    -It comprises of detailed profiles of Sickle Cell Disease therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
    -Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    -Coverage of dormant and discontinued pipeline projects across Sickle Cell Disease

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283177/buying

    Reasons to Buy
    -Establish a comprehensive understanding of the current pipeline scenario across Sickle Cell Disease to formulate effective R&D strategies
    -Assess challenges and opportunities that influence Sickle Cell Disease R&D
    -Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    -Identify the relationship between the products and use it for target finding, drug repurposing, and precision medicine
    -Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Sickle Cell Disease to enhance and expand business potential and scope
    -Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 5+ products along with 5+ companies involved.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW00012283179/sample

    Top Key Players: -
    Acorda Life Sciences
    Astellas Pharma
    Boehringer Ingelheim
    Faron Pharmaceuticals
    Proximagen
    Sucampo Pharmaceuticals

    Products covered by Phase
    -Phase II
    -Pre-clinical
    -Inactive (Dormant and Discontinued)

    Overview of pipeline development activities for Vascular Adhesion Protein 1 (VAP-1) Inhibitors
    Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

    Therapeutic segmentation of products for Vascular Adhesion Protein 1 (VAP-1) Inhibitors
    The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this mechanism.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283179/discount

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    -Provides an overview of therapeutic pipeline activity for Vascular Adhesion Protein 1 (VAP-1) Inhibitors across the complete product development cycle including all clinical and non-clinical stages
    -It comprises of detailed profiles of Vascular Adhesion Protein 1 (VAP-1) Inhibitors therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
    -Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    -Coverage of dormant and discontinued pipeline projects across Vascular Adhesion Protein 1 (VAP-1) Inhibitors

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283179/buying

    Reasons to Buy
    -Establish a comprehensive understanding of the current pipeline scenario across Vascular Adhesion Protein 1 (VAP-1) Inhibitors to formulate effective R&D strategies
    -Assess challenges and opportunities that influence Vascular Adhesion Protein 1 (VAP-1) Inhibitors R&D
    -Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    -Identify the relationship between the products and use it for target finding, drug repurposing, and precision medicine
    -Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Vascular Adhesion Protein 1 (VAP-1) Inhibitors to enhance and expand business potential and scope
    -Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive and discontinued drugs


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type. This report provides detailed analysis of 75+ products along with 65+ companies involved.

    Get a Sample Report: https://www.reportsweb.com/inquiry&RW00012283181/sample

    Top Key Players: -
    Aciont
    Acucela
    Adalta
    Adverum Biotechnologies
    Aerie Pharmaceuticals
    Alimera sciences
    Allegro Opthalmics
    Allergan
    Allergan
    Altacor
    Apexigen
    Ascendis Pharma
    Bayer

    Products covered by Phase
    -Phase III, Phase II and Phase I
    -Pre-clinical and Discovery
    -Inactive (Dormant and Discontinued)

    Overview of pipeline development activities for Wet AMD
    Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

    Therapeutic segmentation of products for Wet AMD
    The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283181/discount

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Publisher's team of industry experts. Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    -Provides an overview of therapeutic pipeline activity for Wet AMD across the complete product development cycle including all clinical and non-clinical stages
    -It comprises of detailed profiles of Wet AMD therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
    -Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
    -Coverage of dormant and discontinued pipeline projects across Wet AMD

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283181/buying

    Reasons to Buy
    -Establish a comprehensive understanding of the current pipeline scenario across Wet AMD to formulate effective R&D strategies
    -Assess challenges and opportunities that influence Wet AMD R&D
    -Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
    -Identify the relationship between the products and use it for target finding, drug repurposing, and precision medicine
    -Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for Wet AMD to enhance and expand business potential and scope
    -Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0
  • 12/04/18--00:00: Xyrem-API Insight 2018
  •  



    (EMAILWIRE.COM, December 04, 2018 ) It further provides Xyrem`s patents information (US & EU). It also features the historical and forecasted sales of Xyrem till 2022. The report also highlights Xyrem`s market competition and emerging therapies which are in the same space as Xyrem.

    Get a Sample Report:  https://www.reportsweb.com/inquiry&RW00012283182/sample

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Publisher's team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283182/discount

    Scope of the report
    -A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
    -Patent information around Xyrem in United States (US) and Europe (EU) has been highlighted
    -API manufacturers for Xyrem in United States and India
    -The report contains historical and forecasted sales for Xyrem till 2022
    -Enlists the market competition and emerging therapies in the space where Xyrem operates

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283182/buying

    Reasons to Buy
    -Establish a comprehensive understanding of the drug, Xyrem
    -Access to Xyrem`s API manufacturers details to devise API procurement strategy for generic development
    -Plan generic developmental timelines around Xyrem`s patents for the major markets-US and EU
    -Understand Xyrem`s current and future growth through its historical and forecasted sales
    -Identify the current in-market competitors for Xyrem
    -Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    -Identify the emerging players and their products operating in the same space as Xyrem


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0
  • 12/04/18--00:00: Yondelis-API Insight 2018
  •  



    (EMAILWIRE.COM, December 04, 2018 ) It includes Yondelis overview, mechanism, regulatory milestones, deals & partnerships, clinical trials and other development activities. It further provides Yondelis`s patents information (US & EU). It also features the historical and forecasted sales of Yondelis till 2020. The report also highlights Yondelis`s market competition and emerging therapies which are in the same space as Yondelis.

    Get a Sample Report:  https://www.reportsweb.com/inquiry&RW00012283183/sample

    Methodology
    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by Publisher's team of industry experts.

    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283183/discount

    Scope of the report
    -A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report
    -Patent information around Yondelis in United States (US) and Europe (EU) has been highlighted
    -API manufacturers for Yondelis in United States, Europe, China and India
    -The report contains historical and forecasted sales for Yondelis till 2020
    -Enlists the market competition and emerging therapies in the space where Yondelis operates

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283183/buying

    Reasons to Buy
    -Establish a comprehensive understanding of the drug, Yondelis
    -Access to Yondelis`s API manufacturers details to devise API procurement strategy for generic development
    -Plan generic developmental timelines around Yondelis`s patents for the major markets-US and EU
    -Understand Yondelis`s current and future growth through its historical and forecasted sales
    -Identify the current in-market competitors for Yondelis
    -Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    -Identify the emerging players and their products operating in the same space as Yondelis


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Multiple Sclerosis . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Multiple Sclerosis for 7 major markets. The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW00012283206/sample

    The market revenue of Multiple Sclerosis is currently accounted by several approved therapies, some of which are dimethyl fumarate (Tecfidera; Biogen), Natalizumab (Tysabri; Biogen), Glatiramer acetate (Copaxone; Teva Pharmaceutical), Gilenya (Novartis), Extavia (Novartis), Aubagio (Sanofi) and others.

    Ocrevus (Roche), a first-in-class anti-CD20 antibody, was approved by U.S.FDA ad EMA in 2017 to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). It is the first drug approved by the FDA for PPMS and is expected to become a blockbuster product in coming years.

    There are many potential therapies under development for Multiple Sclerosis, few of them being Daclizumab (Biogen), Ofatumumab (Novartis Pharmaceuticals), Ponesimod (Actelion), Opicinumab (Biogen), Ozanimod (Celgene), and Ublituximab (TG Therapeutics, Inc.).

    The entry of such potential pipeline candidates, and continued uptake of existing therapies shall act as major market drivers during our forecast period.

    Additionally, the Report highlights the frontrunners, the drivers and barriers for the Multiple Sclerosis market, as well as treatment algorithm, current treatments & advancements are included.

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW00012283206/discount

    The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Multiple Sclerosis , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

    According to Publisher, the forecasted patient population of Multiple Sclerosis for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Multiple Sclerosis 7MM market size is estimated to be USD XX by 2025. The Publisher Report will help in enhanced understanding of the Multiple Sclerosis market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

    Key Coverage

    -Understanding historical and forecasted epidemiological data for Multiple Sclerosis covering 7MM from 2015-2025.
    -Segment level epidemiology and market split for Multiple Sclerosis .
    -The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Multiple Sclerosis .
    -The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Multiple Sclerosis market trends.
    -Thorough market distribution based on market share for Multiple Sclerosis .

    Get More Information : https://www.reportsweb.com/inquiry&RW00012283206/buying

    Reasons to buy:

    -The report will help in developing business strategies by understanding trends shaping and driving the Multiple Sclerosis market.
    -To understand the future market competition in the Multiple Sclerosis market and Insightful review of the key market drivers and barriers.
    -Organize sales and marketing efforts by identifying the best opportunities for Multiple Sclerosis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
    -Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) This report provides information on the therapeutic development based on PD-1 and PD-L1 Inhibitors mechanism of action dealing with around 47+ active pipeline drugs. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Publisher's Report also assesses the PD-1 and PD-L1 Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. The report also covers the information for 36+ active companies involved in the therapeutic development of the products.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW0001608699/sample

    Top Key Players: -
    Agenus Inc
    Alnylam
    AstraZeneca plc
    Aurigene
    BeiGene
    Bristol Myers Squibb
    Cellular Biomedicines Group
    Curis, Inc.
    CytomX Therapeutics
    EMD Serono, Inc
    Enumeral
    GlaxoSmithKline

    Report Scope

    -The report provides competitive pipeline landscape of PD-1 and PD-L1 Inhibitors
    -The report provides the marketed drugs information including its sales, development activities and details of patent expiry
    -The report provides the insight of current and future market for PD and PD-L1 inhibitors
    -The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
    -Coverage of the PD-1 and PD-L1 Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
    -The report reviews key players involved in the therapeutics development for PD-1 and PD-L1 Inhibitors and also provide company profiling
    -The report also gives the information of dormant pipeline projects
    -Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
    -Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW0001608699/discount

    Reasons to Buy

    -Identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage
    -Complete MOA intelligence and complete understanding over therapeutics development for PD-1 and PD-L1 Inhibitors
    -Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
    -Devise corrective measures for pipeline projects by understanding PD-1 and PD-L1 Inhibitors pipeline depth and focus of Indication therapeutics
    -Developing strategic initiatives to support your drug development activities.
    -Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
    -Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
    -Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
    -Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
    -Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

    Get More Information : https://www.reportsweb.com/inquiry&RW0001608699/buying


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) This report provides information on the therapeutic development based on Natural Killer Cells mechanism of action dealing with around 40+ active pipeline drugs. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. Report contains the development and sale activities for marketed drugs. Publisher's Report also assesses the Natural Killer Cells therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration. The report also covers the information for 22+ active companies involved in the therapeutic development of the products.

    Get a Sample Report:   https://www.reportsweb.com/inquiry&RW0001608700/sample

    Top Key Players: -
    Affimed Therapeutics AG
    AltorBioScience Corporation
    AvidBiotic Corporation
    BioLineRx
    Bristol-Myers Squibb
    Celyad
    Dynavax
    Fate Therapeutics
    Five Prime Therapeutics
    Fortress Biotech
    Glycostem Therapeutics

    Report Scope

    -The report provides competitive pipeline landscape of Natural Killer Cells
    -The report provides the marketed drugs information including its sales, development activities and details of patent expiry
    -The report provides the insight of current and future market for Natural Killer Cells
    -The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
    -Coverage of the Natural Killer Cells pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
    -The report reviews key players involved in the therapeutics development for Natural Killer Cells and also provide company profiling
    -The report also gives the information of dormant pipeline projects
    -Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
    -Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

    Get Interesting Discount: https://www.reportsweb.com/inquiry&RW0001608700/discount

    Reasons to Buy

    -Identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage
    -Complete MOA intelligence and complete understanding over therapeutics development for Natural Killer Cells
    -Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
    -Devise corrective measures for pipeline projects by understanding Natural Killer Cells pipeline depth and focus of Indication therapeutics
    -Developing strategic initiatives to support your drug development activities.
    -Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
    -Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
    -Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
    -Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
    -Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

    Get More Information : https://www.reportsweb.com/inquiry&RW0001608700/buying


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail. There are a number of players operating in the market and this research report gives readers overview of the various factors that govern their performance.

    Get a Sample PDF Report: https://www.reportsweb.com/inquiry&RW00012270584/sample



    This study report on global Smart Insulin Pens Market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, and opportunities. A number of analysis tools such as Porter’s five forces analysis and SWOT analysis have been employed to provide an accurate understanding of this market.

    Smart Insulin Pens

    Go For Interesting Discount Here: https://www.reportsweb.com/inquiry&RW00012270584/discount

    An exhaustive study has been carried out on the key players operating in the Global Smart Insulin Pens Market. The report covers the revenue share, cost, product offering, recent developments, gross profit, business overview, and mergers & acquisitions, which helps the customers to understand the key players in a more profound manner. Furthermore, the report covers the different strategies adopted by the key players operating in the market. An in-depth analysis of the market dynamics, including the drivers, restraints, challenges, threats, and the potential growth opportunities have been provided.

    Topmost Leading Manufacturer Covered in this report:
    Emperra, Roche, Diamesco, Companion Medical, Patients Pending, Common Sensing, Jiangsu Delfu, Dnurse,

    Global Smart Insulin Pens Market: Product Segment Analysis:
    Smart Insulin Pens, Smart Pen Caps

    Smart Insulin Pens Market segmentation, by applications:
    Home Care Settings, Hospitals & Clinics, Other

    The Global Smart Insulin Pens Market is defined by means of the presence of some of the main competition working inside the market, consisting of the well-installed players and new entrants, and the suppliers, providers, and distributors. The key gamer are continuously that specialize in increasing their geographic reach and broadening their customer base, so that it will amplify their product portfolio and give you new improvements.

    The record additionally analyzes the development proposals and the feasibility of latest investments. This document has been collated with the intention to offer guidance and route to the organizations and people interested by shopping for this research report.

    Get Full Report @ https://www.reportsweb.com/inquiry&RW00012270584/buying

    Key questions answered in this report:

    -What will be the market size by the end of the forecast period?
    -What are the factors driving the growth of the market?
    -What are the trends and developments that are likely to drive the growth of the market?
    -Who are the key players operating in the market?
    -What are the challenges, threats, and opportunities faced by the leading players?
    -What are the strengths and weaknesses of the key players of the market?

    Note: If you have any special requirements, please let us know and we will offer you the report as you want.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 04, 2018 ) Factors that are boosting the growth of the market, and giving a positive push to thrive in the global market is explained in detail. There are a number of players operating in the market and this research report gives readers overview of the various factors that govern their performance.

    Get a Sample PDF Report: https://www.reportsweb.com/inquiry&RW00012283842/sample

    This study report on global Patient Data Management Systems Market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, and opportunities. A number of analysis tools such as Porter’s five forces analysis and SWOT analysis have been employed to provide an accurate understanding of this market.

    Patient Data Management Systems Market

    Go For Interesting Discount Here: https://www.reportsweb.com/inquiry&RW00012283842/discount

    An exhaustive study has been carried out on the key players operating in the Global Patient Data Management Systems Market. The report covers the revenue share, cost, product offering, recent developments, gross profit, business overview, and mergers & acquisitions, which helps the customers to understand the key players in a more profound manner. Furthermore, the report covers the different strategies adopted by the key players operating in the market. An in-depth analysis of the market dynamics, including the drivers, restraints, challenges, threats, and the potential growth opportunities have been provided.

    Topmost Leading Manufacturer Covered in this report:
    Philips Healthcare, GE Healthcare, Dräger, Radiometer Medical, Cerner, IMD Soft, Elekta, Nexus AG, Mortara, Siemens Healthineers, Smiths Medical, Medset, UTAS,

    Global Patient Data Management Systems Market: Product Segment Analysis:
    Single Function System, Multifunction System

    Global Patient Data Management Systems Market: Application Segment Analysis
    ICUs, General Ward

    The Global Patient Data Management Systems Market is defined by means of the presence of some of the main competition working inside the market, consisting of the well-installed players and new entrants, and the suppliers, providers, and distributors. The key gamer are continuously that specialize in increasing their geographic reach and broadening their customer base, so that it will amplify their product portfolio and give you new improvements.

    The record additionally analyzes the development proposals and the feasibility of latest investments. This document has been collated with the intention to offer guidance and route to the organizations and people interested by shopping for this research report.

    Get Full Report @ https://www.reportsweb.com/inquiry&RW00012283842/buying

    Key questions answered in this report:

    -What will be the market size by the end of the forecast period?
    -What are the factors driving the growth of the market?
    -What are the trends and developments that are likely to drive the growth of the market?
    -Who are the key players operating in the market?
    -What are the challenges, threats, and opportunities faced by the leading players?
    -What are the strengths and weaknesses of the key players of the market?

    Note: If you have any special requirements, please let us know and we will offer you the report as you want.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

older | 1 | .... | 1104 | 1105 | (Page 1106) | 1107 | 1108 | .... | 1118 | newer